- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04691609
Assiut University Registry for ACS Patients During COVID-19 Pandemic
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
In the face of the quickly evolving coronavirus disease 2019 (COVID-19) pandemic, many health-care systems around the globe have modified their routine management of patients presenting with acute cardiovascular emergencies including patients with ACS.A unifying theme in the new management strategies is the adoption of new restrictive measures to meet the challenges of increased risk of infection of health-care workers; limited numbers of beds, shortage of personal protective equipment (PPE), inadequate number of protected catheterization rooms; and the clinical overlap between ACS and COVID-19 infection in some of patients.
In developing countries, with an already strained health system due to economic problems, the situation is more challenging and needs the formulation of efficient protocols that can accommodate several medical and socioeconomic challenges.
Egypt, with an estimated population of 100 million, is facing exceptional challenges during the COVID-19 crisis. Because large scale use of polymerase chain reaction (PCR) test for SARS-CoV-2 in a large population is a problem, the prevalence of COVID-19 infection in Egypt is unknown. Furthermore, the supply of PPE falls far short of demands with lack of professionally protected cardiac catheterization rooms. With progression of the pandemic in such a large population, care of COVID-19 patients is expected to rapidly overwhelm the supplies, beds, and staff available in Egyptian hospitals.
The Cardiology Department in Assiut university hospital has revised the management protocols for ACS patients and implemented new management protocols both for patients with ST-segment elevation myocardial infarction (STEMI) and Non-ST-segment elevation acute coronary syndromes (NSTE-ACS).
Undersøgelsestype
Tilmelding (Forventet)
Kontakter og lokationer
Studiekontakt
- Navn: Samah obiedallah Fouad, resident
- Telefonnummer: 01069612646
- E-mail: samahfouad847@yahoo.com
Undersøgelse Kontakt Backup
- Navn: Amr Ahmed yousef, professor
- Telefonnummer: 01006554042
- E-mail: amryoussef111@yahoo.com
Studiesteder
-
-
Resident
-
Assiut, Resident, Egypten
- Rekruttering
- Samah ObiedAllah Fouad
-
Kontakt:
- Amr Ahmed Yousef, professor
- Telefonnummer: 01006554042
- E-mail: amryoussef111@yohoo.com
-
Kontakt:
- Ayman khairy Hassan, lecturer
- Telefonnummer: 01094438055
- E-mail: aymankhairy11@gmail.com
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Patients presenting with symptoms or ECG indicative of acute coronary syndrome admitted to Assiut heart hospital
Exclusion Criteria:
- The only exclusion criteria is refusal of the patient to participate in the study
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Kohorte
- Tidsperspektiver: Tværsnit
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Main Number, distribution and oucome of all ACS patients coming to Assiut heart hospital
Tidsramme: about 1 year
|
Number, distribution and outcome of all ACS patients coming to Assiut heart hospital(as age, gender, risk factors of coronary artery diseases and their effect on incidence and progress of ACS )
|
about 1 year
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
To register pathological events occurring to all acute coronary syndrome patients coming to Assiut university heart hospital through one year during COVID- 19 pandemic
Tidsramme: about 1 year
|
To evaluate clinical symptoms and signs of COVID -19 and acute coronary syndrome(Type of ACS, type of intervention or treatment for each case,complications if peresent, COVID - 19 status and if it affects ACS patient or not and follow up after 3 months and 1 year)
|
about 1 year
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Studieleder: Ayman Khairy Hassan, Lecturer, aymankhairy11@gmail.com
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- ACS in COVID-19 era
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med ACS-COVID-19-Assiut
-
Yang I. PachankisAktiv, ikke rekrutterendeCOVID-19 luftvejsinfektion | COVID-19 stresssyndrom | COVID-19-vaccinebivirkning | COVID-19-associeret tromboembolisme | COVID-19 Post-Intensive Care Syndrome | COVID-19-associeret slagtilfældeKina
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico og andre samarbejdspartnereAfsluttetPostakutte følgesygdomme af COVID-19 | Tilstand efter COVID-19 | Langtids-COVID | Kronisk COVID-19 syndromItalien
-
Massachusetts General HospitalRekrutteringPostakut COVID-19 syndrom | Lang COVID | Postakutte følgesygdomme af COVID-19 | Lang COVID-19Forenede Stater
-
Dr. Soetomo General HospitalIndonesia-MoH; Universitas Airlangga; Biotis Pharmaceuticals, IndonesiaRekrutteringCovid-19-pandemi | Vacciner mod covid-19 | COVID-19 virus sygdomIndonesien
-
First Affiliated Hospital Xi'an Jiaotong UniversityShangluo Central Hospital; Ankang Central Hospital; Hanzhong Central Hospital og andre samarbejdspartnereRekrutteringKohorteopfølgning af epidemi og neuroimaging for patienter under den første bølge af COVID-19 i KinaCOVID-19 | Post-COVID-19 syndrom | Post-akut COVID-19 | Akut COVID-19Kina
-
Indonesia UniversityRekrutteringPost-COVID-19 syndrom | Lang COVID | Tilstand efter COVID-19 | Post-COVID syndrom | Lang COVID-19Indonesien
-
Erasmus Medical CenterDa Vinci Clinic; HGC RijswijkIkke rekrutterer endnuPost-COVID-19 syndrom | Lang COVID | Lang Covid19 | Tilstand efter COVID-19 | Post-COVID syndrom | Tilstand efter COVID-19, uspecificeret | Post-COVID tilstandHolland
-
University of Witten/HerdeckeInstitut für Rehabilitationsforschung NorderneyAfsluttetPost-COVID-19 syndrom | Long-COVID-19 syndromTyskland
-
Endourage, LLCRekrutteringLang COVID | Lang Covid19 | Post-akut COVID-19 | Langdistance COVID | Langdistance COVID-19 | Post-akut COVID-19 syndromForenede Stater